Current treatment strategies for breast cancer are based on the molecular subtype classification that takes into account cancer cell expression of hormone (estrogen and progesterone) receptors and the human epidermal growth factor 2 receptor (HER2) (2). This evidence concerns the gene ERBB2 and cancer.